6505--Radiopharmaceuticals for nuclear medicine VA patients
ID: 36C26024Q0956Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF260-NETWORK CONTRACT OFFICE 20 (36C260)VANCOUVER, WA, 98662, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/26f063eb978141afb948a41e7a63e54c/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply radiopharmaceuticals for nuclear medicine patients at the Boise VA Medical Center. The procurement aims to ensure the availability of various nuclear medicine supplies over a five-year period, starting November 1, 2024, with requirements for 24/7 availability and emergency deliveries within 90 minutes for urgent orders. This initiative is crucial for providing high-quality medical treatment to VA patients, emphasizing compliance with federal regulations and timely service delivery. Interested parties must submit their proposals by October 3, 2024, at 1:00 PM Pacific Time, and can direct inquiries to Jose E Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.

    Point(s) of Contact
    Jose E Ronstadtjose.ronstadt@va.gov
    (360) 852-9885
    jose.ronstadt@va.gov
    Files
    Title
    Posted
    36C26024Q0956_1.docx
    The solicitation notice outlines a Request for Proposal (RFP) issued by the U.S. Department of Veterans Affairs (VA) for the procurement of radiopharmaceuticals intended for nuclear medicine patients. The contracting office responsible for this solicitation is located in Vancouver, Washington. The response deadline for proposals is set for October 3, 2024, at 1:00 PM Pacific Time. This RFP does not involve Recovery Act funds and is classified under product service code 6505 and NAICS code 325412. Interested parties are directed to refer to document RFQ 36C26024Q0956 for detailed requirements. The notice emphasizes the importance of adhering to submission guidelines and encourages bidders to reach out to the specified point of contact for further inquiries. This RFP is crucial for ensuring that VA nuclear medicine patients receive high-quality radiopharmaceutical products necessary for their medical treatment.
    S02 36C26024Q0956.docx
    The document relates to a federal Request for Proposal (RFP) issued by the Department of Veterans Affairs, specifically for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the supply of radiopharmaceuticals to the Boise VA Medical Center. The solicitation outlines the requirements for various nuclear medicine supplies needed over a five-year period, starting November 1, 2024. It details the delivery timelines, order placement procedures through existing software, and responsibilities of Nuclear Medicine Technicians. The contractor must ensure availability of radiopharmaceuticals 24/7, with emergency deliveries required within 90 minutes for urgent orders. Pricing must be quoted for multiple years, with an understanding that actual quantities might fluctuate. The document emphasizes compliance with federal regulations, invoicing standards, and identifies clauses related to contract administration and payment procedures. It signifies the government's commitment to providing adequate medical supplies for nuclear medicine, highlighting protocols for quality and timely services necessary for patient care.
    Lifecycle
    Title
    Type
    6505--Radiopharmaceuticals for nuclear medicine VA patients
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.
    Q527--Intent to Sole Source Radiopharm Isotopes-Wilkes-Barre VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 4, intends to issue a sole source contract for the provision of Radiopharmaceutical Isotopes to the Wilkes-Barre VA Medical Center, specifically with Jubilant Draximage Radiopharmaceuticals Inc. The contract aims to ensure the timely delivery of radiopharmaceuticals that comply with U.S. Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) regulations, thereby prioritizing patient safety and effective healthcare for veterans. This procurement is critical for maintaining high-quality medical services, as the contractor will be required to adhere to strict quality control measures, provide emergency services, and ensure proper packaging and labeling of all materials supplied. Interested vendors must submit a capability statement by September 20, 2024, to the Contracting Specialist, Christa Stine, at christa.stine@va.gov.
    6505--Ga68 PSMA Injection (Illucix)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.
    6505--Notice of Intent to Sole Source Pluvicto and Lutathera
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Advanced Accelerator Applications USA for the provision of Pluvicto and Lutathera, specialized radiopharmaceuticals used in the treatment of metastatic castration-resistant prostate cancer and gastroenteropancreatic neuroendocrine tumors. This procurement is justified under FAR regulations due to the unique and highly specialized nature of the therapies required, which limits the availability of suitable suppliers. Interested parties are invited to submit their capability statements, including qualifications and relevant contract information, by 10:00 AM PT on September 25, 2024, to Peter Kim at peter.kim33@va.gov. The contracting office is located in Long Beach, CA, and responses must be submitted electronically; failure to respond may result in the contract being awarded without further solicitation.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    Q517--Hazardous Compounding
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for hazardous compounding services to support the Gulf Coast Veterans Health Care System, specifically for providing compounded hazardous chemotherapy agents at its facilities in Biloxi, MS, and Pensacola, FL. The contract will be structured as a firm-fixed price, indefinite-delivery, indefinite-quantity agreement, with a base period from October 1, 2024, to September 30, 2025, and the option for four additional one-year extensions. This procurement is critical for ensuring the timely and compliant delivery of essential medical treatments to veterans, adhering to FDA and USP standards while emphasizing quality assurance and regulatory compliance. Interested contractors should submit their proposals and past performance questionnaires by 12 PM CT on September 20, 2024, and can direct inquiries to Contracting Officer Tina L. Harris at Tina.Harris3@va.gov.
    Teleradiology Services for VASNHCS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services for the Veterans Affairs Southern Nevada Health Care System (VASNHCS). The contract requires certified or board-eligible radiology physicians to provide remote diagnostic imaging services, including CT, MRI, and ultrasound scans, in accordance with strict American College of Radiology standards. This procurement is critical for ensuring timely and accurate diagnostic services for veterans, with an estimated total contract value of $19 million over the performance period from December 1, 2024, to November 30, 2029. Interested vendors should contact Maricela A Berrones-Gauger at maricela.berrones-gauger@va.gov for further details and to submit proposals, adhering to the Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside requirements.
    Q522--Teleradiology Physician Services - VANEOHS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking Teleradiology Physician Services for the Northeast Ohio Healthcare System (VANEOHS) to provide 24/7 interpretations of Diagnostic Imaging procedures, along with in-house IT support. This procurement will consist of five one-year ordering periods, reflecting the VA's commitment to enhancing healthcare delivery through specialized remote radiology services. The solicitation for these services is expected to be available on or about September 20, 2024, with a response deadline set for October 18, 2024, at 2:00 PM Eastern Time. Interested parties can contact Contracting Specialist Karen Williams at Karen.Williams4@va.gov or by phone at 614-257-5220 for further details.
    H165--H165- Radiation Physicist contract
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for a Radiation Physicist contract to provide diagnostic radiation services at the Southern Arizona VA Healthcare System in Tucson, Arizona. The contractor will be responsible for furnishing all necessary labor, materials, equipment, and qualified personnel to ensure compliance with federal, local, and VA regulations for various diagnostic imaging units, including radiography units, CT scanners, and MRI machines. This contract, valued at approximately $19.5 million, spans a base year from October 1, 2024, to September 30, 2025, with four optional one-year extensions available through 2029. Interested parties should submit their proposals by September 27, 2024, and can contact Marie Conforto at marie.conforto@va.gov for further information.